THEONYS
Theonys is a patient-focused drug discovery company that's harnessing the power of tRNA to pioneer an entirely new class of genomic medicines. The company is advancing Precision Translational Reprogramming as a novel approach to treating complex, multigenic diseases like cancer. The company was launched in 2020 by Nick Davis and Pete Dedon at MIT, Richard Gregory at Harvard, and Tom Begley at UAlbany — world experts in tRNA network biology and cancer — and is headquartered in Cambridge, Massachusetts.
THEONYS
Industry:
Biotechnology Life Science Medical
Founded:
2020-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.theonys.com
Total Employee:
11+
Status:
Closed
Contact:
6175465726
Email Addresses:
[email protected]
Total Funding:
13.37 M USD
Current Employees Featured
